Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026

Please enable cookies. Error 1015 Ray ID: a135aa612c23750d • 2026-06-29 14:36:48 UTC You are being rate limited What happened? The owner of this website (investors.nuvationbio.com) has banned you temporarily from accessing this website. Please see https://developers.cloudflare.com/support/troubleshooting/http-status-codes/cloudflare-1xxx-errors/error-1015/ for more details. Was this page helpful? Yes No Thank you for your feedback! Cloudflare Ray ID: a135aa612c23750d • Your IP: Click to reveal 81.193.37.7 • Performance & security by Cloudflare